Radiosurgery and Radiotherapy Robotics Market Size, Share, Growth, and Industry Growth By Type (X-ray Based, Gamma-ray Based, and Proton-beam Based) By Application (Hospital, Clinic, and Others), Regional Forecast To 2031

Updated On: 20 November 2023

Radiosurgery and Radiotherapy Robotics Market REPORT OVERVIEW

• 
• Request Free Sample to learn more about this report

The global radiosurgery & radiotherapy robotics market size was USD 3813 million in 2022 and is projected to touch USD 5612.54 million by 2031, CAGR of 4.4% during the forecast period.

Radiosurgery typically involves the removal of tumour cells using ionized radiation beams and is used to treat cancer. Similar to radiosurgery, radiotherapy treats the tumour with many fractionated doses of radiation over the course of several sittings. During the projection period, these two treatment methods are anticipated to become important means of treating both malignant and non-cancerous tumours.

The market is expected to grow substantially during the forecast period due to the increasing burden of different types of cancers. Cancer remains one of the leading causes of death across the world and is widely prevalent across individuals of all age groups. Increasing R&D in the healthcare industry along with increasing investments in the adoption of new technologies will propel the market growth. Advanced solutions such as radiotherapy and radiosurgery robotics will be key tools in addressing the increasing burden of various chronic and life-threatening diseases, including cancer. Increasing popularity of these technologies will create a favorable growth outlook for the market in the forthcoming years.

COVID-19 Impact: Risk of COVID-19 Transmission Shifted Boost Towards Robotics

The healthcare sector is anticipated to see a long-lasting effect of the global COVID-19 pandemic. The pandemic forced locals have led to the emergence of a new set of needs and requirements that weren't previously present, with the most crucial one being the need for medical robotics, which is critical in hospitals to reduce contact between patients and healthcare professionals and prevent the spread of pathogens. Due to non-contact patient procedures and treatments, the COVID-19 pandemic outbreak has a beneficial effect on the global and United States radiosurgery and radiotherapy robotics market growth. Additionally, owing to importance and necessity at this vital time, several foreign governments, like those of the U.S., China, Korea, and Japan, are completely focused on producing robots for use in the medical and surgical fields. Given the spreading nature of the pandemic and the need to strengthen healthcare systems, the adoption of radiosurgery and radiotherapy robots is expected to rise over the next few years, driven by robust investments by healthcare providers and the respective governments.

LATEST TRENDS

"Increasing Use of Advanced Technologies to Push Market Demand"

The main drivers of the market expansion for radiosurgery robotic systems are the rising occurrences of brain cancer and spinal cancer, the demand for minimally invasive surgical techniques, and the rising acceptance of robotic technology. In addition, compared to other traditional surgical methods, radiosurgery robots' high tumor-treating effectiveness and effective dosage manipulation are anticipated to increase demand for these systems. The deployment of robotic radiosurgery devices is anticipated to rise as a result of significant technological advancements. By generating composite photos, the integrated planning software in radiosurgery robotic systems enables the formulation of extremely complicated plans, such as donut-shaped dose distribution, and also prevents overexposure to crucial structures.

Radiosurgery and Radiotherapy Robotics Market Segmentation

• 
• Request Free Sample to learn more about this report

• By Type Analysis

By type, market is segmented into X-ray based, gamma-ray based and proton-beam based. X-ray segment will dominate the market in the coming years.

• By Application Analysis

Based on applications, the market is classified into hospital, clinic, and others. The hospital segment will lead the global and United States radiosurgery and radiotherapy robotics market share through 2028.

DRIVING FACTORS

"Increasing Need of Advanced Treatments to Stimulate Market Growth"

The market for radiosurgery and radiotherapy robotic systems is expected to grow as more individuals are diagnosed with brain and spinal tumours, technology advances, significant R&D practises, and cancer management and treatment awareness rise. The market is anticipated to grow as a result of rising demand for radiosurgery robotic systems from emerging nations like China, India, and Japan. The market in Asia Pacific is also being driven by an increase in the use of minimally invasive treatments and knowledge of cancer therapy.

"Widespread Occurrence of Cancer to Create New Opportunities"

The occurrence of cancer has increased tenfold in recent years and it continues impact the quality of life of millions of individuals across the world. To address the rising burden of the disease, the healthcare industry is shifting towards more advanced treatments and solutions based on robotics as they are more efficient, accurate, and reliable compared to conventional solutions. Increasing investments from the healthcare sector towards the adoption of latest advanced technologies such as robotics will positively influence the market outlook.

RESTRAINING FACTORS

"High Initial Cost Could Affect Product Demand"

In emerging and underdeveloped nations, the market for new radiosurgery robotic systems has been constrained by affordability and lack of availability. Due to high level of sophistication offered by radiosurgery and radiotherapy robots, the cost required to manufacture and maintain them is slightly on the higher side. These factors may limit the adoption of these robots across certain developing regions. 

Radiosurgery and Radiotherapy Robotics Market REGIONAL INSIGHTS

• 
• Request Free Sample to learn more about this report

"North America to Dominate Led by Increasing Adoption of Latest Technologies "

Due to the rising prevalence of cancer, the demand for new and creative surgical procedures for the treatment of cancer by healthcare institutions, and the increased acceptance of new cutting-edge techniques for the treatment of cancer, North America leads the global market. Increasing adoption rate of new advanced technologies and a robust healthcare infrastructure will strengthen the regional outlook.

The second-largest market share is accounted for by Europe. A few of the reasons driving the expansion of the market in Europe include the increased use of cutting-edge cancer treatment methods, such as radiosurgery and radiotherapy, in nations such as Germany, the U.K., and France. The growing prevalence of tumors also serves as a key factor driving the regional market.

KEY INDUSTRY PLAYERS

"Key Players Focus on Partnerships to Gain a Competitive Advantage "

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio.

List of Market Players Profiled

• Accuray (U.S.)
• Brainlab (Germany)
• Varian Medical Systems (U.S.)
• Elekta (UK)
• Best Theratronics (Canada)
• Huiheng Medical (China)
• MASEP Medical Science (China)
• Technology (UK)
• Development (U.S.)
• Neusoft Medical Systems (China)
• ViewRay (U.S.)
• Zhuhai Hokai Medical Instruments (China)

REPORT COVERAGE

The market research study examines the worldwide market in detail, focusing on important elements such as leading players, product/services or type, and leading end-use applications. Aside from that, the research analyses major advancements and provides insights into lighting market trends. In addition to the causes indicated above, the paper includes a number of other factors that have contributed to recent growth.